Biocure Technology Inc. announced a non-brokered private placement of 12,500 shares at an issue price of CAD 4.328 per share for gross proceeds of CAD 54,100 on January 17, 2023. The company holds now 93.42% interest in BPK.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.005 CAD | 0.00% |
|
-50.00% | -66.67% |
06-30 | Atriva Therapeutics GmbH cancelled the acquisition of Biocure Technology Inc. | CI |
05-21 | Biocure Technology Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
1st Jan change | Capi. | |
---|---|---|
-66.67% | 343K | |
+14.30% | 22.32B | |
-1.17% | 2.8B | |
+32.56% | 2.24B | |
-11.48% | 1.62B | |
-2.98% | 1.1B | |
-16.50% | 782M | |
-5.34% | 312M | |
-15.73% | 79.83M |
- Stock Market
- Equities
- CURE.X Stock
- News Biocure Technology Inc.
- Biocure Technology Inc. announced that it has received CAD 0.0541 million in funding